Galt stock price today
WebHow much is Galectin Therapeutics stock worth today? (NASDAQ: GALT) Galectin Therapeutics currently has 59,426,005 outstanding shares. ... Galectin Therapeutics 's market cap is calculated by multiplying GALT's current stock price of $1.96 by GALT's total outstanding shares of 59,426,005.
Galt stock price today
Did you know?
WebJun 6, 2024 · NORCROSS, Ga., June 06, 2024 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, today announced that the Company ... WebApr 6, 2024 · finance.yahoo.com - December 13 at 10:10 AM. Galectin Therapeutics Inc.'s (NASDAQ:GALT) stock has dropped to US$2.83, but insiders may have sold too soon at a price of only US$2.17 a share. nasdaq.com - November 18 at 1:55 PM.
WebMar 31, 2024 · The stock price for Galectin Therapeutics ( NASDAQ: GALT) is $ 1.96 last updated March 17, 2024 at 8:00 PM UTC. Q. WebGalectin Therapeutics stock quote and GALT charts. Latest stock price today and the US's most active stock market forums. Galectin Therapeutics (GALT) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more. Support: 888-992-3836 Home NewsWire Subscriptions
WebAfter-Hours Trades. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is … WebApr 13, 2024 · The stock has a market capitalization of $121.26 million, a PE ratio of -3.14 and a beta of 1.45. Galectin Therapeutics has a 12 month low of $1.02 and a 12 month …
Web1 hour ago · Galectin Inhibitors Drugs Have Emerged As New Focused Domain For Cancer Clinical Researchers Says Kuick ResearchDelhi, April 14, 2024 (GLOBE NEWSWIRE) -- Global Galectin Inhibitors Market Trends ...
WebDec 31, 2024 · 59,0%. More Financials. Company. Galectin Therapeutics Inc. is a biotechnology company that is focused on developing therapies to improve the lives of patients with fibrotic disease, chronic liver disease and cancer. The Company’s product candidates include galectin-3 inhibitor, which is a belapectin (GR-MD-02) and GM-CT-01. top heavy investmentWebJul 9, 2024 · This is a stock that has seen a 52-week trading range of $1.82 to $5.70. At a current price of around $3.50 per share, Galectin is right in the middle of the range. Accordingly, momentum traders ... top heavy gifWebApr 10, 2024 · A high-level overview of Galectin Therapeutics Inc. (GALT) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and … top heavy key employee definitionWebGet the latest Galectin Therapeutics Inc. (GALT) stock news and headlines to help you in your trading and investing decisions. top heavy engineering companies in indiaWebApr 14, 2024 · StockNews.com started coverage on shares of Galectin Therapeutics (NASDAQ:GALT – Get Rating) in a report issued on Thursday. The brokerage issued a hold rating on the stock. Separately, HC Wainwright reissued a buy rating and set a $11.00 price target on shares of Galectin Therapeutics in a report on Friday, March 3rd. top heavy fractionsWeb2 days ago · View Galectin Therapeutics Inc GALT investment & stock information. Get the latest Galectin Therapeutics Inc GALT detailed stock quotes, stock data, Real-Time … top heavy gigachadWebMar 27, 2024 · Get Galectin Therapeutics Inc (GALT:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. top heavy fiddle leaf fig